ALB and anemia (phenotype): For patients after neoadjuvant therapy, due to its side effects, it tends to lead to bone marrow suppression as well as increased body metabolism, causing complications such as anemia and hypoproteinemia, which are usually treated accordingly by clinicians, such as blood transfusion and human albumin input, etc. Wait until 4–6 weeks after the end of neoadjuvant therapy, and then the thoracic surgeon to assess the feasibility of surgery.